Topsalysin Seen to Help Some Localized Prostate Cancer Patients in Small Study

Topsalysin Seen to Help Some Localized Prostate Cancer Patients in Small Study
Some patients with localized prostate cancer were seen to benefit from treatment with topsalysin (PRX302) in a small Phase 2a proof-of-concept trial (NCT02499848), according to Sophiris Bio. Findings from the trial were presented at this year’s 112th American Urology Association meeting by Edward J. Bass, University College London. The poster was titled “Intra-Prostatic PRX302 Focal Therapy in Treating

Knowledge is power when living with prostate cancer.

Get access to the web’s leading Prostate Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Tagged , , , .

Joana brings more than 8 years of academic research and experience as well as Scientific writing and editing to her role as a Science and Research writer. She also served as a Postdoctoral Researcher at the Center for Neuroscience and Cell Biology in Coimbra, Portugal, where she also received her PhD in Health Science and Technologies, with a specialty in Molecular and Cellular Biology.

One comment

Leave a Comment

Your email address will not be published. Required fields are marked *